GL1X · GenesisL1 explorer

MolNFT v1 · #65747 · protein

Catalytic domain of human SERINE/THREONINE phosphatase 5 (PP5C) with two MN2+ atoms originally soaked with norcantharidin (which is present in the structure in the hydrolyzed form)

3H61 · SERINE/THREONINE-protein phosphatase 5: “Catalytic domain of human SERINE/THREONINE phosphatase 5 (PP5C) with two MN2+ atoms originally soaked with…”. X-ray diffraction, 2 ligands (ENL, MN), 1 pocket (best druggability 0.64). MolNFT…

PDB
3H61
Type
protein
Length
630 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein phosphatase 5
EC
3.1.3.16
UniProt
P53041
Ligands
ENL, MN
Pockets
1 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, DSERINE/THREONINE-protein phosphatase 5 (EC 3.1.3.16)protein31535% helix, 21% strandP53041

Ligands and binding sites

  • ENL · (1R,2S,3R,4S)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid · ligand · 2 copies · chains A, D
  • MN · Manganese (II) ion · metal · 4 copies · chains A, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16570.640.7462ENL

Interfaces

1 interface between chains.

  • A–D · 169 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3H61 · Catalytic domain of human Serine/Threonine Phosphatase 5 (PP5c) with two Mn2+ atoms… · the same entry in another collection · chain A against A, TM-score 1.00
  • P53041 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein phosphatase 5 (P53041) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.